Dr. Brian Druker, M.D.

Claim this profile

OHSU Knight Cancer Institute

Studies Clonal Cytopenia
Studies Low blood cell count
2 reported clinical trials
2 drugs studied

Affiliated Hospitals

Image of trial facility.
Oregon Health & Science University (Data Collection Only)

Clinical Trials Brian Druker, M.D. is currently running

More about Brian Druker, M.D.

Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Brian Druker, M.D. has experience with
  • Enasidenib
  • Ivosidenib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Druker, M.D. specialize in?
Brian Druker, M.D. focuses on Clonal Cytopenia and Low blood cell count. In particular, much of their work with Clonal Cytopenia has involved IDH positive patients, or patients who are undergoing treatment.
Is Brian Druker, M.D. currently recruiting for clinical trials?
Yes, Brian Druker, M.D. is currently recruiting for 1 clinical trial in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Brian Druker, M.D. has studied deeply?
Yes, Brian Druker, M.D. has studied treatments such as Enasidenib, Ivosidenib.
What is the best way to schedule an appointment with Brian Druker, M.D.?
Apply for one of the trials that Brian Druker, M.D. is conducting.
What is the office address of Brian Druker, M.D.?
The office of Brian Druker, M.D. is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.